|
Platelet function inhibitors
Citations 231-240 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Basic Science Reports
Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries
- James K. Hennan, Jinbao Huang, Terrance D. Barrett, Edward M. Driscoll, David E. Willens, Andrew M. Park, Leslie J. Crofford, and Benedict R. Lucchesi
Circulation 2001;104:820-825, doi:10.1161/hc3301.092790
[Abstract]
[Full text]
- Clinical Investigations and Reports
Randomized Comparison of Ticlopidine and Clopidogrel After Intracoronary Stent Implantation in a Broad Patient Population
- Megumi Taniuchi, Howard I. Kurz, and John M. Lasala
Circulation 2001;104:539-543, doi:10.1161/hc3001.093435
[Abstract]
[Full text]
- Clinical Investigations and Reports
Pharmacodynamics and Pharmacokinetics of Higher-Dose, Double-Bolus Eptifibatide in Percutaneous Coronary Intervention
- Ian C. Gilchrist, J. Conor O’Shea, Teddy Kosoglou, Lisa K. Jennings, Todd J. Lorenz, Michael M. Kitt, Neal S. Kleiman, David Talley, Frank Aguirre, Charles Davidson, John Runyon, and James E. Tcheng
Circulation 2001;104:406-411, doi:10.1161/hc2901.093504
[Abstract]
[Full text]
- Clinical Investigations and Reports
Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization
- A. Michael Lincoff, Dean J. Kereiakes, Mary A. Mascelli, Lawrence I. Deckelbaum, Elliot S. Barnathan, Kamlesh K. Patel, Bart Frederick, Marian T. Nakada, and Eric J. Topol
Circulation 2001;104:163-167
[Abstract]
[Full text]
- Clinical Investigations and Reports
Aspirin, Warfarin, or the Combination for Secondary Prevention of Coronary Events in Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Surgery
- Thao Huynh, Pierre Théroux, Peter Bogaty, James Nasmith, and Susan Solymoss
Circulation 2001;103:3069-3074
[Abstract]
[Full text]
- Clinical Investigations and Reports
Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status : The PARAGON-B Troponin T Substudy
- L. Kristin Newby, E. Magnus Ohman, Robert H. Christenson, David J. Moliterno, Robert A. Harrington, Harvey D. White, Paul W. Armstrong, Frans Van de Werf, Matthias Pfisterer, Vic Hasselblad, Robert M. Califf, and Eric J. Topol
Circulation 2001;103:2891-2896
[Abstract]
[Full text]
- Clinical Investigations and Reports
Select Flavonoids and Whole Juice From Purple Grapes Inhibit Platelet Function and Enhance Nitric Oxide Release
- Jane E. Freedman, Crawford Parker, III, Liqing Li, Jacob A. Perlman, Balz Frei, Vadim Ivanov, Leslie R. Deak, Mark D. Iafrati, and John D. Folts
Circulation 2001;103:2792-2798
[Abstract]
[Full text]
- Editorials
Monitoring Platelet Function in Glycoprotein IIb/IIIa Inhibitor Therapy
- Kenneth K. Wu and James T. Willerson
Circulation 2001;103:2528-2530
[Full text]
- Clinical Investigations and Reports
Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction : A TIMI 14 Substudy
- C. Michael Gibson, James A. de Lemos, Sabina A. Murphy, Susan J. Marble, Carolyn H. McCabe, Christopher P. Cannon, Elliott M. Antman, and Eugene Braunwald
Circulation 2001;103:2550-2554
[Abstract]
[Full text]
- Clinical Investigations and Reports
Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention : Results of the GOLD (AU-Assessing Ultegra) Multicenter Study
- Steven R. Steinhubl, J. David Talley, Gregory A. Braden, James E. Tcheng, Peter J. Casterella, David J. Moliterno, Frank I. Navetta, Peter B. Berger, Jeffrey J. Popma, George Dangas, Richard Gallo, David C. Sane, Jorge F. Saucedo, Gang Jia, A. Michael Lincoff, Pierre Theroux, David R. Holmes, Paul S. Teirstein, and Dean J. Kereiakes
Circulation 2001;103:2572-2578
[Abstract]
[Full text]
|
|
